BioPorto A/S 2021 Annual Report with Sustainability Disclosures
Company: BioPorto A/S
Sector: Professional & technical services
Country: Denmark
Year: 2021
Type: Annual Report with Sustainability Disclosures
Pages: 78
The report describes BioPorto's 2021 progress toward FDA clearance of The NGAL Test for pediatric use in the US, although COVID-19 delayed patient enrollment. It highlights a new executive team and Board changes, and reports group revenue of DKK 24.3 million. The report also includes corporate-responsibility disclosures covering human rights, labor rights, environment, anti-corruption, privacy and the UN Global Compact.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.